Clinical trial
A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in…
NCT00476151 · EpiCept Corporation, Industry · Completed
Key facts
| NCT number | NCT00476151 |
|---|---|
| Title | A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EpiCept™ NP-1 Topical Cream in Patients With Pain From Diabetic Peripheral Neuropathy (DPN) |
| Lead sponsor | EpiCept Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Peripheral Neuropathy, Neuralgia |
| Intervention type | Drug |
| Interventions | EpiCept NP-1 (4% Amitriptyline/ 2% Ketamine) Topical Cream, placebo cream |
| Enrollment | 226 |
| Start date | Jul 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 21, 2007 |
| Last update posted | May 17, 2011 |
| Countries | India |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: